Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
SOSVs program for startups with a hardware element|Cyril Ebersweiler,General Partner,HAX
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
General Partner at SOSV and the founder/MD of HAX.
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Prospect Resources Advances Arcadia Lithium Project Amidst Positive DFS Results
00:10:00
Multinationals. Swimmingly easy payments | Joachim Samuelsson, CEO, Crunchfish ABCFISH:STO
00:10:00
Navarre Minerals: Advancing Gold Exploration in Victoria, Australia with Promising Prospects and Aggressive Growth Plans
00:10:00
Thoughts on gaming in crypto, NFTs, work-life balance and more|Ramnik Arora,Head of Product,FTX
00:00:00
Abivax seeks partners - Dr. Hartmut Ehrlich, CEO, Abivax
00:10:00
S&P Chooses Humanica for Enhanced Human Resource Management: A Testimonial on Payroll Outsourcing | Soontorn Dentham - Vice Chairman and CEO of Humanica
00:00:00
Jan Adriaan (Arjan) Haverhals Chief Executive Officer and President, Milestone Scientific Inc
00:10:00
SiTime CEO Rajesh Vashist appears on CNBC's Mad Money.
00:10:00
Mike Speetzen, Polaris CEO, discusses investor day, earnings, and the state of high-ticket consumers on 'Closing Bell: Overtime'.|Jae-Ho Kim is Director & Head-Management Support at Polaris Office Corp.
00:10:00
GoldSource Mines: Advancing the High-Return Eagle Mountain Gold Project in Guyana
00:10:00
Mynaric Revolutionizes Communication with Free Space Laser Technology for Air and Space Networks |Bulent Altan , CEO , Mynaric AG.
00:10:00
Interpreting Global Financial Trends: A Discussion on Central Banks, China, and Investment Strategies | Stephen Bird, CEO , Abrdn .